Guangjian B. Yang

Jinan, 250117, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

First-line pyrotinib plus apatinib in advanced non-small cell lung cancer harboring HER2 mutations or amplification: a phase II trial.

First-line pyrotinib plus apatinib in advanced non-small cell lung cancer harboring HER2 mutations or amplification: a phase II trial.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 20, 2026

Aumolertinib in non-small cell lung cancer with uncommon EGFR exon 19 deletions: a real-world dual-center study.

Aumolertinib in non-small cell lung cancer with uncommon EGFR exon 19 deletions: a real-world dual-center study.

Journal: BMC cancer

Published: January 23, 2026

Clinicopathological Profiles and Prognosis of Postoperative HER2-Mutant Non-Small Cell Lung Cancer: A Real-World Analysis.

Clinicopathological Profiles and Prognosis of Postoperative HER2-Mutant Non-Small Cell Lung Cancer: A Real-World Analysis.

Journal: Current cancer drug targets

Published: November 06, 2025

Tumor Immune Microenvironment and Clinicopathological Characteristics of Thoracic NUT Carcinoma.

Tumor Immune Microenvironment and Clinicopathological Characteristics of Thoracic NUT Carcinoma.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: August 18, 2025

Iruplinalkib for G1202R-mutant non-small cell lung cancer with anaplastic lymphoma kinase double fusion failed to alectinib: a case report.

Iruplinalkib for G1202R-mutant non-small cell lung cancer with anaplastic lymphoma kinase double fusion failed to alectinib: a case report.

Journal: Anti-cancer drugs

Published: February 14, 2025

Lung adenocarcinoma harboring uncommon EGFR exon 19 deletion L747_T751del and in cis K754E mutation: a case report and literature review.

Lung adenocarcinoma harboring uncommon EGFR exon 19 deletion L747_T751del and in cis K754E mutation: a case report and literature review.

Journal: Discover oncology

Published: January 31, 2025

Promising Response to Pyrotinib in Non-Small-Cell Lung Cancer with the Rare HER2 R456C Mutation: A Case Report.

Promising Response to Pyrotinib in Non-Small-Cell Lung Cancer with the Rare HER2 R456C Mutation: A Case Report.

Journal: Current cancer drug targets

Published: December 01, 2024

Formation of metal-microplastic complexes in lung adenocarcinoma is associated with increased risk of cancer progression.

Formation of metal-microplastic complexes in lung adenocarcinoma is associated with increased risk of cancer progression.

Journal: Journal of hazardous materials

Published: November 19, 2024

Pulmonary NUT carcinoma, an elusive and refractory entity, shows transient response to chemotherapeutics and PD-1 inhibitor: a case report and literature review.

Pulmonary NUT carcinoma, an elusive and refractory entity, shows transient response to chemotherapeutics and PD-1 inhibitor: a case report and literature review.

Journal: Frontiers in immunology

Published: September 16, 2024

Hyperprogressive disease induced by PD-1 inhibitor monotherapy in lung adenocarcinoma with HER2 exon 20 insertion: report of two cases and review of literature.

Hyperprogressive disease induced by PD-1 inhibitor monotherapy in lung adenocarcinoma with HER2 exon 20 insertion: report of two cases and review of literature.

Journal: Discover oncology

Published: September 09, 2024

Dynamic characterization of circulating tumor DNA in HER2-altered advanced non-small cell lung cancer treated with pyrotinib and apatinib: Exploratory biomarker analysis from PATHER2 study.

Dynamic characterization of circulating tumor DNA in HER2-altered advanced non-small cell lung cancer treated with pyrotinib and apatinib: Exploratory biomarker analysis from PATHER2 study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 04, 2024

Thoracic epithelioid inflammatory myofibroblastic sarcoma: a rare and aggressive disease with case report and literature review.

Thoracic epithelioid inflammatory myofibroblastic sarcoma: a rare and aggressive disease with case report and literature review.

Journal: Discover oncology

Published: June 25, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026